KATIONISCHES LIPID

European patent · EP3178807 · In force

Register entry

Publication number
EP3178807
Application number
EP15829025
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 6, 2015
Published
Jun 14, 2017
Granted
Apr 29, 2020
Protection ends at the latest
Aug 5, 2035
Next annual fee due
Aug 31, 2026
IPC classes
C07C 229/12 (2006.01)
A61K 9/51 (2006.01)
A61K 31/7105 (2006.01)
A61K 31/713 (2006.01)
A61K 47/18 (2017.01)
A61K 48/00 (2006.01)
A61P 43/00 (2006.01)
C12N 15/113 (2010.01)
A61K 9/127 (2006.01)
Priority
JP 2014161718 07.08.2014
PCT application
PCT/JP2015/072344 06.08.2015
PCT publication
WO2016/021683 11.02.2016
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  3. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  4. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  5. May 8, 2020

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 08.05.2020

  6. Apr 29, 2020

    Granted

    Published in Swissreg on 29.04.2020

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

HOASHI Yasutaka

Fujisawa-shi Kanagawa 251-0012, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.